Allison Duettmann will challenge Aubrey De Grey with the top objections against longevity to be debunked and debated before opening up the floor to the public.
The goal is to create a comprehensive Longevity FAQ that tackles all things longevity from boredom and meaning, saving lives and living forever, fate and freedom of choice, overpopulation and social disparities, opportunities and risks, investment and commercialization – to tips and tricks for those who want a positive, long life.
Longevity skeptics and evangelists alike, please bring your best questions, arguments, and strategies for a healthy debate!
IndieBio, the world’s first accelerator devoted to startups using biology to solve the world’s largest problems.
Foresight Institute, a non-profit focused on advancing technologies of fundamental importance for the future of life.
6.30 pm – 9 pm @IndieBio, San Francisco
6.30 pm: Foresight & IndieBio community mixer
7 – 7.10 pm: Welcome with Alex Kopelyan
7.10 – 8 pm: Discussion with Aubrey De Grey & Allison Duettmann
8 – 8.30 pm: Q&A with the audience
8.30 – 9 pm: Foresight & IndieBio community mixer
Aubrey de Grey, Ph.D.
SENS Chief Science Officer and Co-founder
Dr. de Grey is the biomedical gerontologist who researched the idea for and founded SENS Research Foundation. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.
Program Director, Foresight Institute
Allison Duettmann is a Researcher and Program Director at Foresight Institute. Her focus is on strategies to reduce existential risks, e.g. AGI Strategy & Coordination. At Existentialhope.com she maps promising work toward positive long-term futures. Allison holds a Summa Cum Laude MS in Philosophy & Public Policy from the London School of Economics, where she developed an NLP-based ethical framework for AGI.
Program Director, IndieBio
Alex Kopelyan is a Partner and Program Director at IndieBio. As part of the investment team he sets direction for the portfolio, works with startups during IndieBio and beyond, and bridges the broader community of investors, academia, and industry. He holds a PharmD and has a background in clinical pharmacy, nutrition, and behavioral medicine.
>> If you find this content valuable, you may use this link to share this email. <<
Join our movement! Follow our Facebook page, Twitter or connect to our professional network on Linkedin for regular updates, as well as invites to our upcoming events. To get an overview of the different ways to accelerate our mission, we created a one-pager on Getting Involved.
That said, one of the ways that you can most immediately help is to support our mission financially. For a detailed summary of what your donations accomplish, see our Progress Report for 2018: Accomplishments and concrete 2019 plans.
>> If you find this content valuable, you can use this link to share this email. <<